Bayer AG - Stockholders' Newsletter First Quarter 2008

News

Nexavar® approved in Japan
Bayer has been granted marketing approval for Nexavar® in Japan for the treatment of advanced renal cell carcinoma, the most common form of kidney cancer. » more

1:36 min.

Protect potatoes from late blight
Fungicidal active ingredient receives registrations
Fluopicolide, the latest active ingredient in the Bayer CropScience fungicides portfolio, has received regulatory approval in Japan and the United States. » more

1:43 min.

Protecting the climate
New biofuel source offers great potential
Bayer CropScience AG and other companies plan to jointly explore the potential for Jatropha in the biodiesel industry. » more

1:51 min.

Baytubes®
Carbon nanotubes for new thermoplastic materials
The excellent electrical conductivity and mechanical strength of Baytubes® carbon nanotubes were the decisive factors leading to a cooperation agreement. » more

1:16 min.

News Overview

Key Data
Bayer Group
Net Sales, EBITDA, EBIT, Net income, Cash flow, Non-operating result, Number of Employees » more

Bayer Stock Key Data
Investor Information
Bayer stock could not escape the turbulence on the international stock markets in the first quarter. » more

Group Management Report
Overview of Sales, Earnings and Financial Position
The Bayer Group posted excellent first-quarter results, carrying over the previous year’s positive trend into 2008. » more

Financial Statements
Interim Financial Statements as of March 31, 2008
Statements of Income, Balance Sheets, Statements of Cash Flows, Statements of Recognized Income and Expense » more